Logo image
Recipient side of TRALI: The role of patient neutrophils
Journal article   Peer reviewed

Recipient side of TRALI: The role of patient neutrophils

Yoke Lin Fung
ISBT Science Series, Vol.2(2), pp.135-140
2007
url
https://doi.org/10.1111/j.1751-2824.2007.00129.xView
Published Version

Abstract

Clinical Sciences laboratory investigation serology TRALI transfusion recipient
Transfusion-related acute lung injury (TRALI) is a serious and potentially fatal complication of blood transfusions. The fact that TRALI has been the top cause of transfusion-related mortalities in the USA over the last 3 years (2004-06) [1] provides irrefutable evidence of the clinical significance of this syndrome. From this perspective, its importance in transfusion complications surpasses that of blood-borne viruses and bacterial infections. Despite this, we still do not clearly understand the pathophysiology and pathogenesis of TRALI. This paper presents a TRALI patient or recipient perspective by discussing how thorough serological investigations can be utilized to provide evidence that patient neutrophils are the target cell and to identify the implicated donation/s when there are multiple associated donations.

Details

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Web Of Science research areas
Health Care Sciences & Services
Hematology
Public, Environmental & Occupational Health

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image